Pharmabiz

Kymera Therapeutics receives US FDA Fast Track Designation for KT-621, an oral STAT6 degrader to treat atopic dermatitis

Kymera Therapeutics receives US FDA Fast Track Designation for KT-621, an oral STAT6 degrader to treat atopic dermatitis: Watertown, Massachusetts Saturday, December 13, 2025, 18: ...
Pharmabiz

Vektor Medical receives US FDA 510(k) clearance for its next-generation vMap technology to enhance connectivity

Vektor Medical receives US FDA 510(k) clearance for its next-generation vMap technology to enhance connectivity: San Diego Saturday, December 13, 2025, 17:00 Hrs [IST] Vektor Medi ...
Pharmabiz

InnoCare Pharma’s next-generation TRK inhibitor zurletrectinib gets China NMPA approval to treat NTRK fusion-positive tumours

InnoCare Pharma’s next-generation TRK inhibitor zurletrectinib gets China NMPA approval to treat NTRK fusion-positive tumours: Beijing Saturday, December 13, 2025, 16:30 Hrs [IS ...
Pharmabiz

OTR Therapeutics and Zealand Pharma ink license agreement to develop novel therapeutics for metabolic diseases

OTR Therapeutics and Zealand Pharma ink license agreement to develop novel therapeutics for metabolic diseases: Shanghai Saturday, December 13, 2025, 16:00 Hrs [IST] OTR Therapeut ...
Pharmabiz

Researchers demonstrate environment and climate shape regional patterns of allergic sensitization

Researchers demonstrate environment and climate shape regional patterns of allergic sensitization: Krems, Austria Saturday, December 13, 2025, 15:00 Hrs [IST] Allergic sensitizati ...
Pharmabiz

Gaelic Labs acquires Athlone Laboratories to strengthen Gaelic’s leadership in Beta Lactam industry

Gaelic Labs acquires Athlone Laboratories to strengthen Gaelic’s leadership in Beta Lactam industry: Ireland Saturday, December 13, 2025, 14:00 Hrs [IST] Gaelic Laboratories, es ...
Pharmabiz

Panel concerned over gap between budget allocated to MoA & its impact on implementation of various projects

Raising concerns over the continuing gap between the budget allocated to the Ministry of Ayush (MoA) and its impact on the implementation of various projects, the Parliamentary Panel on Health and ...
Pharmabiz

EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older

EMA committee recommends approval of GSK’s RSV vaccine, Arexvy for all adults 18 years and older: London, UK Saturday, December 13, 2025, 13:00 Hrs [IST] GSK plc announced that ...
Pharmabiz

Atai Beckley receives US patent for drug substance EMP-01, strengthening intellectual property portfolio

Atai Beckley receives US patent for drug substance EMP-01, strengthening intellectual property portfolio: New York Saturday, December 13, 2025, 12:00 Hrs [IST] Atai Beckley NV, a ...
Pharmabiz

Amgen receives US FDA approval for Uplizna to treat Adults with generalized myasthenia gravis

Amgen receives US FDA approval for Uplizna to treat Adults with generalized myasthenia gravis: Thousand Oaks, California Saturday, December 13, 2025, 11:00 Hrs [IST] Amgen announc ...
Pharmabiz

Autobahn Labs signs partnership with Astellas Pharma to speed up academic discoveries into novel medicines

Autobahn Labs signs partnership with Astellas Pharma to speed up academic discoveries into novel medicines: Palo Alto, California Saturday, December 13, 2025, 10:00 Hrs [IST] Auto ...
Pharmabiz

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea

US FDA approves GSK’s Blujepa as oral option for treatment of uncomplicated urogenital gonorrhoea: London, UK Saturday, December 13, 2025, 09:00 Hrs [IST] GSK plc announced that ...